DE60222422D1 - Mutationen in ionenkanälen - Google Patents
Mutationen in ionenkanälenInfo
- Publication number
- DE60222422D1 DE60222422D1 DE60222422T DE60222422T DE60222422D1 DE 60222422 D1 DE60222422 D1 DE 60222422D1 DE 60222422 T DE60222422 T DE 60222422T DE 60222422 T DE60222422 T DE 60222422T DE 60222422 D1 DE60222422 D1 DE 60222422D1
- Authority
- DE
- Germany
- Prior art keywords
- subject
- mutations
- ion channels
- ion channel
- undergone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR6452A AUPR645201A0 (en) | 2001-07-18 | 2001-07-18 | Mutations in ion channels |
AUPS0910A AUPS091002A0 (en) | 2002-03-05 | 2002-03-05 | Mutations in ion channels |
AUPS2292A AUPS229202A0 (en) | 2002-05-13 | 2002-05-13 | Novel mutations |
PCT/AU2002/000910 WO2003008574A1 (en) | 2001-07-18 | 2002-07-08 | Mutations in ion channels |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60222422D1 true DE60222422D1 (de) | 2007-10-25 |
Family
ID=27158306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60222422T Expired - Lifetime DE60222422D1 (de) | 2001-07-18 | 2002-07-08 | Mutationen in ionenkanälen |
Country Status (9)
Country | Link |
---|---|
US (2) | US20050074764A1 (de) |
EP (2) | EP1852505B1 (de) |
JP (1) | JP2005501536A (de) |
AT (1) | ATE373089T1 (de) |
AU (1) | AU2002318972B8 (de) |
CA (1) | CA2454073C (de) |
DE (1) | DE60222422D1 (de) |
NZ (2) | NZ530258A (de) |
WO (1) | WO2003008574A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ530258A (en) * | 2001-07-18 | 2006-01-27 | Bionomics Ltd | Mutations in SCN1A SCN2A SCN3A SCN8A sodium ion channels and their use in diagnosing epilepsy |
US7709225B2 (en) * | 2001-07-18 | 2010-05-04 | Bionomics Limited | Nucleic acids encoding mutations in sodium channels related to epilepsy |
AU2003904154A0 (en) * | 2003-08-07 | 2003-08-21 | Bionomics Limited | Mutations in ion channels |
JP2005537285A (ja) | 2002-07-30 | 2005-12-08 | ワイス | ラパマイシンヒドロキシエステルを含有する非経口製剤 |
AU2003901425A0 (en) | 2003-03-27 | 2003-04-10 | Bionomics Limited | A diagnostic method for epilepsy |
AU2004263548B2 (en) * | 2003-08-07 | 2007-09-13 | Bionomics Limited | Mutations in ion channels |
JP2007537712A (ja) * | 2003-10-13 | 2007-12-27 | バイオノミックス リミテッド | 新生児てんかん症候群または乳児てんかん症候群についての診断方法 |
CA2578071A1 (en) * | 2004-12-24 | 2006-06-29 | Ares Trading S.A. | Compositions and methods for treating mental disorders |
CA2612180A1 (en) * | 2005-06-16 | 2006-12-21 | Bionomics Limited | Methods of treatment, and diagnosis of epilepsy by detecting mutations in the scn1a gene |
US20100311610A1 (en) * | 2008-02-01 | 2010-12-09 | Chromocell Corporation | CELL LINES AND METHODS FOR MAKING AND USING THEM (As Amended) |
EP2770325A1 (de) | 2013-02-26 | 2014-08-27 | Institut du Cerveau et de la Moelle Epiniere-ICM | Mutationen von DEPDC5 zur Diagnose von epileptischen Funktionsstörungen, Erkrankungen oder Leiden |
JP7312451B2 (ja) * | 2018-01-26 | 2023-07-21 | 国立大学法人東海国立大学機構 | 受容体タンパク質を標的とする治療薬、検査薬、受容体タンパク質に結合する抗体、及び分子標的薬のスクリーニング方法 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4016043A (en) * | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
US4172124A (en) * | 1978-04-28 | 1979-10-23 | The Wistar Institute | Method of producing tumor antibodies |
US4474893A (en) * | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
US4971903A (en) * | 1988-03-25 | 1990-11-20 | Edward Hyman | Pyrophosphate-based method and apparatus for sequencing nucleic acids |
US5331573A (en) | 1990-12-14 | 1994-07-19 | Balaji Vitukudi N | Method of design of compounds that mimic conformational features of selected peptides |
NO175199C (no) | 1991-12-05 | 1994-09-14 | Kvaerner Fjellstrand As | Flerskrogfartöy |
AU701228B2 (en) * | 1995-06-28 | 1999-01-21 | University Of Bonn | Diagnostic and treatment methods relating to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) |
US5646040A (en) | 1995-06-30 | 1997-07-08 | Millennium Pharmaceutical, Inc. | Mammalian tub gene |
US6331614B1 (en) * | 1998-12-23 | 2001-12-18 | Myriad Genetics, Inc. | Human CDC14A gene |
DE1252330T1 (de) * | 1999-11-26 | 2003-11-27 | Univ Montreal Mcgill | Loci der idiopathischen epilepsie, mutationen derselben und verfahren zu deren verwendung zur feststellung, prognose und behandlung von epilepsie |
US6703439B2 (en) * | 2000-02-09 | 2004-03-09 | Mitsui Chemicals, Inc. | Polyolefin resin composition and polyolefin film prepared from the same |
AUPQ749100A0 (en) | 2000-05-12 | 2000-06-08 | Bionomics Limited | New epilespy gene |
EP1767637A1 (de) | 2000-06-20 | 2007-03-28 | Bionomics Limited | Mutation, welche mit Epilepsie assoziiert ist |
AUPQ882600A0 (en) | 2000-07-18 | 2000-08-10 | Bionomics Limited | Mutations in ion channels |
US6661614B2 (en) * | 2000-09-27 | 2003-12-09 | Seagate Technology Llc | Magnetless actuator for disc drive |
AUPR220300A0 (en) | 2000-12-20 | 2001-01-25 | Bionomics Limited | New epilepsy gene |
AUPR492201A0 (en) | 2001-05-10 | 2001-06-07 | Bionomics Limited | Novel mutation |
US7709225B2 (en) * | 2001-07-18 | 2010-05-04 | Bionomics Limited | Nucleic acids encoding mutations in sodium channels related to epilepsy |
AU2003904154A0 (en) * | 2003-08-07 | 2003-08-21 | Bionomics Limited | Mutations in ion channels |
NZ530258A (en) | 2001-07-18 | 2006-01-27 | Bionomics Ltd | Mutations in SCN1A SCN2A SCN3A SCN8A sodium ion channels and their use in diagnosing epilepsy |
US7282336B2 (en) * | 2001-07-18 | 2007-10-16 | Bionomics Limited | Method of diagnosing epilepsy |
AU2002351175A1 (en) * | 2001-11-26 | 2003-06-10 | Bristol-Myers Squibb Company | Novel human g-protein coupled receptor, hgprbmy31, and variants and methods of use thereof |
AU2003901425A0 (en) * | 2003-03-27 | 2003-04-10 | Bionomics Limited | A diagnostic method for epilepsy |
CA2612180A1 (en) * | 2005-06-16 | 2006-12-21 | Bionomics Limited | Methods of treatment, and diagnosis of epilepsy by detecting mutations in the scn1a gene |
-
2002
- 2002-07-08 NZ NZ530258A patent/NZ530258A/en not_active IP Right Cessation
- 2002-07-08 DE DE60222422T patent/DE60222422D1/de not_active Expired - Lifetime
- 2002-07-08 AU AU2002318972A patent/AU2002318972B8/en not_active Expired
- 2002-07-08 EP EP07075566A patent/EP1852505B1/de not_active Expired - Lifetime
- 2002-07-08 NZ NZ542048A patent/NZ542048A/en not_active IP Right Cessation
- 2002-07-08 EP EP02748429A patent/EP1407013B1/de not_active Expired - Lifetime
- 2002-07-08 AT AT02748429T patent/ATE373089T1/de not_active IP Right Cessation
- 2002-07-08 JP JP2003514891A patent/JP2005501536A/ja active Pending
- 2002-07-08 WO PCT/AU2002/000910 patent/WO2003008574A1/en active IP Right Grant
- 2002-07-08 US US10/482,834 patent/US20050074764A1/en not_active Abandoned
- 2002-07-08 CA CA2454073A patent/CA2454073C/en not_active Expired - Lifetime
-
2010
- 2010-01-29 US US12/696,769 patent/US7989182B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20050074764A1 (en) | 2005-04-07 |
AU2002318972B2 (en) | 2007-03-08 |
US7989182B2 (en) | 2011-08-02 |
EP1407013B1 (de) | 2007-09-12 |
AU2002318972A1 (en) | 2003-03-03 |
CA2454073A1 (en) | 2003-01-30 |
JP2005501536A (ja) | 2005-01-20 |
WO2003008574A1 (en) | 2003-01-30 |
EP1852505B1 (de) | 2010-03-31 |
ATE373089T1 (de) | 2007-09-15 |
CA2454073C (en) | 2012-08-28 |
NZ530258A (en) | 2006-01-27 |
EP1407013A1 (de) | 2004-04-14 |
US20100136623A1 (en) | 2010-06-03 |
AU2002318972B8 (en) | 2007-08-09 |
EP1852505A1 (de) | 2007-11-07 |
EP1407013A4 (de) | 2005-06-22 |
NZ542048A (en) | 2008-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60222422D1 (de) | Mutationen in ionenkanälen | |
ZA200703433B (en) | Identification of a JAK2 mutation in polycythemia vera | |
HK1131744A1 (en) | Toll like receptor 3 antagonists, methods and uses toll | |
AR036160A1 (es) | Regulacion de las vias metabolicas lipidicas en las plantas, mediante transgenesis con sentido o antisentido de factores de transcripcion hap2, hap5 y hap3/lec1 | |
CY1109382T1 (el) | ΠΑΡΑΛΛΑΓΕΣ ΠΕΡΙΟΧΗΣ Fc | |
HK1086283A1 (en) | Antibodies that bind cell-associated ca 125/0722p and methods of use thereof | |
PL2185686T3 (pl) | Komórki dendrytyczne | |
AR015687A2 (es) | Gen aislado que codifica acil transferasa | |
WO2005027710A3 (en) | Methods for identifying subjects at risk of melanoma and treatments thereof | |
GB2453506A (en) | Video encoding | |
DE602004009932D1 (de) | Netzwerkgerät, System und Verfahren zur Authentifizierung | |
WO2006046994A3 (en) | Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk | |
EE200100234A (et) | PRV-1-geen ja selle kasutamine | |
ATE318933T1 (de) | Nukleinsäurefragmente zur identifizierung von dechlorierenden bakterien | |
ATE447586T1 (de) | Fprl1-liganden und deren verwendung | |
DE69930370D1 (de) | Testisspezifische, menschliche proteinase, svph1-8 | |
NO20020064D0 (no) | Chlamysin B antibakterielt protein, gen som koder for dette samt et ekspresjonssystem for dette | |
DE602005018326D1 (de) | Für orotat-transporter codierende markergene | |
DE69939583D1 (de) | Chondrosarcom-assoziierte gene | |
WO2003025225A3 (en) | Pthr1 gene polymorphisms | |
DK1794294T3 (da) | Rekombinant carboxypeptidase B | |
Driscoll et al. | Response from driscoll and colleagues | |
WO2005031341A3 (en) | Methods for predicting development of insulin resistance | |
TW200621983A (en) | Fungi non-ltr retrotransposons and methods related thereto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |